CRISPR Therapeutics AG

Report date
6/30/2026
Quarter
2026 Q2
Filed
8/24/2026
Shares
98,168
Value ($000)
5,354
Weight
0.0%
2021 Q3 - 2026 Q2 (20 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).